September 20, 2017 2:40 PM ET


Company Overview of Anterion Therapeutics, Inc.

Company Overview

Anterion Therapeutics, Inc. engages in the research, development, preclinical and human testing, manufacturing, and licensing of sustained release drug delivery systems primarily in the form of bioerodible implants. Its products include Choless, an implant for lowering bad cholesterol and triglycerides without affecting good cholesterol; Annuelle, a female contraceptive; MasQcept, a male contraceptive; Compliemens, an estrogen implant for the treatment of vaso-motor effects of menopause; Reproxine, a replacement of thyroid hormone; and Ambulin and other peptides for enhancing the growth level of hormones. The company was founded in 2003 and is based in Salem, Massachusetts.

Shetland Park

35 Congress Street

Salem, MA 01970

United States

Founded in 2003





Key Executives for Anterion Therapeutics, Inc.

Anterion Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Anterion Therapeutics, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at